Challenges for biomedical informatics and pharmacogenomics

Annual Review of Pharmacology and Toxicology

Volumn 42, Issue , 2002, Pages 113-133

  Altman, Russ B ^a   Klein, Teri E ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Bioinformatics; Computation; Databases; Pharmacogenetics

Indexed keywords

BIOINFORMATICS; CELL KINETICS; COMPARATIVE GENE MAPPING; COMPUTER AIDED DESIGN; COMPUTER LANGUAGE; CONFIDENTIALITY; DATA BASE; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HUMAN; INFORMATION PROCESSING; MEDICAL INFORMATICS; MEDLINE; MOLECULAR GENETICS; MOLECULAR MODEL; PHARMACOGENOMICS; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING;

COMMUNICATION; COMPUTATIONAL BIOLOGY; CONFIDENTIALITY; DATABASES; GENOMICS; GENOTYPE; HUMANS; PHARMACOGENETICS; PHENOTYPE;

EID: 0036173893     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.42.082401.140850     Document Type: Review

References (109)

1. Biocomputational methodology: An adjunct to theory and applications
2. GeneMarkS: A self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions
3. Finding the genes in genomic DNA
4. Annotating eukaryote genomes
5. Current status of computational gene finding: A perspective
6. Three-dimensional cluster analysis identifies interfaces and functional residue clusters in proteins
7. Protein structure prediction
8. Whole-genome expression analysis: Challenges beyond clustering
9. Neural model of genetic network
10. Extracting knowledge from dynamics in gene expression
11. A literature network of human genes for high-throughput analysis of gene expression
12. Protein-protein interaction maps: A lead towards cellular functions
13. Computational studies of gene regulatory networks: In numero molecular biology
14. Phenotypic and dynamical transitions in model genetic networks. I. Emergence of patterns and genotype-phenotype relationships
15. Gene mapping in the 20th and 21st centuries: Statistical methods, data analysis, and experimental design
16. Genetical genomics: The added value from segregation
17. Automated diagnosis of data-model conflicts using metadata
18. Sequencing the entire genomes of free-living organisms: The foundation of pharmacology in the new millennium
19. Technology evaluation: SAGE, Genzyme molecular oncology
20. An integrated approach for genome-wide gene expression analysis
21. Towards an understanding of complex protein networks
22. Understanding, improving and using green fluorescent proteins
23. Mass spectrometry innovations in drug discovery and development
24. Determination of protein function, evolution and interactions by structural genomics
25. Pharmacogenomics: Translating functional genomics into rational therapeutics
26. Pharmacogenomics: A clinician's primer on emerging technologies for improved patient care
27. Genotype or phenotype: The definition of a pharmacogenetic polymorphism
28. Pharmacogenomics: Unlocking the human genome for better drug therapy
29. Current pharmacogenomic approaches to clinical drug development
30. Prospective CYP2D6 genotyping as an exclusion criterion for enrollment of a phase III clinical trial
31. Automated mass spectrometry: A revolutionary technology for clinical diagnostics
32. Impact of pharmacogenomics on the clinical laboratory
33. How to manage individualized drug therapy: Application of pharmacogenetic knowledge of drug metabolism and transport
34. Human nicotinamide N-methyltransferase pharmacogenetics: Gene sequence analysis and promoter characterization
35. Screening a large reference sample to identify very low frequency sequence variants: Comparisons between two genes
36. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
37. Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma
38. Phase I clinical and pharmacogenetic study of weekly TAS103 in patients with advanced cancer
39. Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy
40. The promise of comparative genomics in mammals
41. Comparative genomics: The key to understanding the Human Genome Project
42. High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: Practice, problems and promise
43. The essence of SNPs
44. Single nucleotide polymorphisms and the future of genetic epidemiology
45. Notes from the SNP vs. haplotype front
46. Analysis of proteins and proteomes by mass spectrometry
47. GenBank
48. Future vision of the GDB human genome database
49. dbSNP: The NCBI database of genetic variation
50. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
51. Online Mendelian Inheritance in Man (OMIM)
52. Online Mendelian Inheritance in Man (OMIM) as a knowledgebase for human developmental disorders
53. A database for cell signaling networks
54. TRANSFAC: An integrated system for gene expression regulation
55. The protein kinase resource
56. Applications of biochip and microarray systems in pharmacogenomics
57. A gene expression database for the molecular pharmacology of cancer
58. Transcriptional profiling in cancer: The path to clinical pharmacogenomics
59. The unified medical language system
60. A functional-phylogenetic classification system for transmembrane solute transporters
61. The P450 superfamily: Update on new sequences, gene mapping, accession
62. P450 superfamily: Update on new sequences, gene mapping, accession numbers
63. SOPHIA: A flexible, web-based knowledge server
64. Domain ontologies in software engineering: Use of Protege with the EON architecture
65. The protein data bank
66. Kleisli: A new tool for data integration in biology
67. Linking up with Entrez
68. PNAD-CSS: A workbench for constructing a protein name abbreviation dictionary
69. A set-covering approach to specific search for literature about human genes
70. Mining literature for protein-protein interactions
71. EDGAR: Extraction of drugs, genes and relations from the biomedical literature
72. Genome-wide analysis relating expression level with protein subcellular localization
73. Computational genetics: Finding protein function by nonhomology methods
74. Use of keyword hierarchies to interpret gene expression patterns
75. DNA microarray analysis of complex biologic processes
76. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network
77. Basic microarray analysis: Grouping and feature reduction
78. Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis
79. Pharmacogenomics and schizophrenia
80. Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites
81. Structural genomics: An overview
82. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases
83. Prediction of the binding site of 1-benzyl-4[(5,6-dimethoxy-1-indanon-2-yl)methyl] piperidine in acetylcholinesterase by docking studies with the SYSDOC program
84. CombiDOCK: Structure-based combinatorial docking and library design
85. Comparative protein structure modeling. Introduction and practical examples with modeller
86. Integration of genome data and protein structures: Prediction of protein folds, protein interactions and "molecular phenotypes" of single nucleotide polymorphisms
87. Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: Structure-based assessment of amino acid variation
88. FlexE: Efficient molecular docking considering protein structure variations
89. QSD quadratic shape descriptors. 2. Molecular docking using quadratic shape descriptors (QSDock)
90. Use of pair potentials across protein interfaces in screening predicted docked complexes
91. Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4
92. Protein docking using spherical polar Fourier correlations
93. A computational system for modelling flexible protein-protein and protein-DNA docking
94. Active conservation of noncoding sequences revealed by three-way species comparisons
95. Alignment of whole genomes
96. The EcoCyc and MetaCyc databases
97. The Kyoto encyclopedia of genes and genomes - KEGG
98. Cluster analysis and promoter modelling as bioinformatics tools for the identification of target genes from expression array data
99. Analysis of gene expression data with pathway scores
100. Generation of mouse mutants as a tool for functional genomics
101. Organization of heterogeneous scientific data using the EAV/CR representation
102. A DNA polymorphism discovery resource for research on human genetic variation
103. Privacy and medical-records research
104. A security mediator for health care information
105. Guaranteeing anonymity when sharing medical data, the Datafly System
106. Determining the identifiability of DNA database entries